Springer Nature
Browse
13046_2019_1216_MOESM3_ESM.docx (93.1 kB)

Additional file 3: of Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib

Download (93.1 kB)
journal contribution
posted on 2019-05-31, 05:00 authored by Ning Zheng, Weiqun Liu, Bifei Li, Huifang Nie, Jian Liu, Yunlong Cheng, Jichuang Wang, Haiyan Dong, Lee Jia
Figure S3.1H NMR spectra of PLGA-PEG-COOH copolymer. (DOCX 93 kb)

Funding

National Natural Science Foundation of China

History

Usage metrics

    Journal of Experimental & Clinical Cancer Research

    Categories

    Keywords

    Hepatocellular carcinomaSorafenibMetapristoneSDF-1/CXCR4PLGA-PEGCombination therapy

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC